GL1X · GenesisL1 explorer

Research workbench

Identification of a novel allosteric binding site for rorgt inhibitors

Analyse Identification of a novel allosteric binding site for rorgt inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5C4U
Type
protein
Length
241 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Nuclear receptor ror-gamma
UniProt
P51449
Ligands
4Y7
Pockets
5 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANuclear receptor ror-gammaprotein24171% helix, 4% strandP51449

Ligands and binding sites

  • 4Y7 · 4-{1-[2-chloro-6-(trifluoromethyl)benzoyl]-1H-pyrazolo[4,3-b]pyridin-3-yl}-5-fluoro-2-hydroxybenzoic acid · ligand · chains A
  • GOL · Glycerol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14050.820.9036GOL
21920.790.93254Y7
31400.510.7920empty
4690.400.7912empty
5540.260.7313empty

Compared structures

  • 5C4U · Identification of a Novel Allosteric Binding Site for RORgt Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.